Patents by Inventor Takeshi Muneta

Takeshi Muneta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220160779
    Abstract: The present inventors have clarified that activin has an activity of promoting the proliferation of MSCs and an activity of promoting the regeneration of meniscus or cartilaginous tissue without affecting differentiation multipotency. Further, the present inventors have also found that the use of activin makes it possible to treat and prevent meniscus damage or cartilage disorders, including suppression of degenerative degeneration of cartilage and pain.
    Type: Application
    Filed: March 19, 2020
    Publication date: May 26, 2022
    Applicant: National University Corporation Tokyo Medical and Dental University
    Inventors: Kunikazu TSUJI, Miyoko OJIMA, Takeshi MUNETA, Hideyuki KOGA, Ichiro SEKIYA
  • Publication number: 20140294971
    Abstract: Proliferation of cancer cells is effectively inhibited. Provided is a cancer cell-inhibiting ceramic containing a ?-tricalcium phosphate porous granule with a particle size of 1 to 10 ?m. The ?-tricalcium phosphate porous granule is taken up into cancer cells at an affected area and have an effect of inhibiting proliferation of a cancer tissue. The ?-tricalcium phosphate porous granule with a particle size of 1 to 10 ?m can be used to more effectively inhibit the proliferation of the cancer cells.
    Type: Application
    Filed: June 13, 2014
    Publication date: October 2, 2014
    Applicants: OLYMPUS CORPORATION, National University Corporation Tokyo Medical and Dental University
    Inventors: Ichiro SEKIYA, Takeshi MUNETA, Yasuharu HAKAMATSUKA
  • Publication number: 20100178274
    Abstract: An object of the present invention is to provide a method for treating defects of articular cartilage or meniscus of a patient using in vivo chondrogenesis of synovium-derived MSCs. The present invention provides a method for treating a disease associated with defects of cartilage or meniscus. In the present invention, the method for treating a disease associated with defects of cartilage or meniscus comprises the following steps: culturing ex vivo autologous synovium-derived mesenchymal stem cells (MSCs); implanting the MSCs such that said cartilage defect site or meniscal defect site is covered by the MSCs; and regenerating cartilage tissue at the cartilage defect site or meniscal defect site in situ by differentiating the MSCs into cartilage cells.
    Type: Application
    Filed: August 22, 2007
    Publication date: July 15, 2010
    Inventors: Ichiro Sekiya, Takeshi Muneta, Tomohiro Morio, Norio Shimizu, Yasuyuki Kuroiwa
  • Publication number: 20060008904
    Abstract: By rotating a cell-culture container while controlling the temperature and the gaseous atmosphere, cells are cultured under the application of hydrostatic pressure due to centrifugal force, and according to this cell culture, cells are efficiently activated and cultured while inhibiting dedifferentiation.
    Type: Application
    Filed: August 26, 2003
    Publication date: January 12, 2006
    Inventors: Junzo Tanaka, Toshiyuki Ikoma, Takeshi Muneta